Clinical Trial Update: HER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in Russia

View source ↗

Summary

A completed clinical trial in Russia evaluating a treatment for HER2-positive metastatic breast cancer sponsored by AstraZeneca has finished.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: COMPLETED